Start With a Clearer View of Your Commercial HCP Targets Before Launch

Complimentary Commercial Target Analysis for Pre-Commercial Pharma Teams


Your pharma launch strategy depends on knowing who your potential HCP targets are, where gaps may exist and how ready your data is to support field execution. MedPro’s Commercial Target Analysis helps emerging pharma teams assess the health and completeness of their target universe before launch, so they can move forward with greater clarity and confidence.

Plan for a Stronger Target Universe Before Launch

Early targeting decisions can shape field readiness, commercial planning and launch performance. But for many pre-commercial teams, initial target lists are often incomplete, inconsistent or difficult to operationalize.

MedPro helps you evaluate your provided HCP target list to uncover potential data quality issues, identify gaps and provide recommendations to strengthen your commercial data foundation before launch.

With a Commercial Target Analysis, your team can:

  • Assess the quality and completeness of your current HCP target list 
  • Identify inactive, incomplete or potentially misaligned records 
  • Uncover opportunities to refine your target universe 
  • Support stronger planning for field readiness and commercial execution 
  • Reduce last-minute data cleanup as pharma launch timelines approach 

What You’ll Receive

Data Quality Assessment

Gain insight into the overall health of your HCP target list, including potential gaps, inconsistencies, duplicate records or incomplete data points that could impact launch readiness.

Key Findings Summary

Receive a clear summary of findings that highlights opportunities to improve data accuracy, strengthen targeting and better prepare your teams for launch.

Recommended Next Steps

MedPro will provide guidance on how to improve your commercial data foundation and support a more confident transition from pre-commercial planning to pharma launch execution.

Why it Matters for Pre-Commercial Teams

Preparing for commercialization requires more than systems alone. Understanding how to structure your data strategy early can help you avoid delays and support stronger execution at launch.

As your organization moves through Phase III, NDA/BLA review and pre-launch planning, accurate HCP data can help inform targeting, support compliance processes and enable field teams to operate with confidence from day one. 

Starting with validated data can help your team avoid unnecessary rework, improve planning visibility and focus resources where they matter most.  

Scientist in protective gear operates equipment in a modern lab.

HOW WE SUPPORT YOUR PHARMA LAUNCH READINESS


MedPro brings decades of experience supporting life sciences organizations with healthcare license validation, data governance and commercial data strategy. Our approach helps pre-commercial teams build a data foundation that is:

Authoritative

Structured for Commercial Use

Ready for Integration

Scalable Beyond Launch


Continue Building Your Launch Readiness Strategy

Your Commercial Target Analysis can help you understand the health of your HCP target universe. MedPro’s Pre-Commercial Launch Readiness Guide provides supplemental support, offering practical guidance on building a scalable commercial data foundation before launch. 

Download the guide to learn how early data decisions can support stronger targeting, compliant engagement, field readiness and long-term growth. 


DRIVEN BY DATA


MedProID is the industry’s most accurate, comprehensive and trusted source of HCP and HCO identifying data, accessible in real-time through a centralized platform that integrates directly with your internal systems.

  • 33 million HCP and HCO Records
  • 25+ Years of Historical Licensing Information
  • 800+ Active Life Sciences Customers

Powered By Service


Collaborate with and rely on our tenured, friendly and knowledgeable team. We don’t just know the data, we know how it can help the operational effectiveness of your business. With over 25 years of experience, you will be supported by our proactive team and personalized service from day one.


Frequently Asked Questions

A Commercial Target Analysis is a complimentary review of your existing target list. Our team assesses data quality, identifies gaps and risks in the records and provides recommendations to strengthen targeting ahead of launch. It is offered at no cost to pre-commercial Life Sciences organizations preparing for first launch.

This analysis is designed for pre-commercial pharmaceutical companies preparing for launch, especially teams in Phase III, NDA/BLA review or early commercial planning. 

MedPro will assess your existing HCP target list. The specific file requirements and secure sharing process can be discussed with a MedPro representative. 

By identifying gaps, inconsistencies or risks early, your team can strengthen its commercial data foundation before field teams are active, systems are finalized and launch timelines become more compressed. 


SEE WHAT YOU’RE MISSING BEFORE LAUNCH

REQUEST AN ANALYSIS